Boston Scientific (Natick, Massachusetts) made a move to significantly expand its portfolio of devices for peripheral inteventions by agreeing to acquire the interventional division of Bayer (Leverkusen, Germany) for $415 million in cash. Bayer Interventional is based near Minneapolis.